Tofacitinib
FDA Approved
Contents
Description
Tofacitinib is a Janus kinase (JAK) inhibitor used to treat autoimmune conditions. It works by blocking the activity of JAK enzymes, which are involved in inflammation and immune response.
Indications & Therapeutic Use
Idiopathic giant-cell myocarditis
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Tofacitinib — GNH India
26 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Betrecep 5mg
5mgtabletIndia
TOFASHINE XR
11 mgtabletIndia
Tofatas
5mgtabletIndia
Xeljanz
EU
Xeljanz 5 UK
5mg
XELJANZ XR
11 mg/1tablet, film coated, extended releaseUSA
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Tofacitinib
| Generic Name | Tofacitinib |
| Brands | 1 brand available |
| Active Ingredient | Tofacitinib |
| Drug Class | Idiopathic giant-cell myocarditis |
| Manufacturer | Pfizer |
| Dosage Forms | Oral tablet |
| Medical Code | L04AA29 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT02147714 |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes